Shockwave Medical Stock (NASDAQ:SWAV), Analyst Ratings, Price Targets, Predictions

The latest price target for Shockwave Medical (NASDAQ: SWAV) was reported by CL King on April 8, 2024. The analyst firm set a price target for $0.00 expecting SWAV to fall to within 12 months (a possible -100.00% downside). 30 analyst firms have reported ratings in the last year.

The latest analyst rating for Shockwave Medical (NASDAQ: SWAV) was provided by CL King, and Shockwave Medical downgraded their neutral rating.

The last upgrade for Shockwave Medical Inc happened on July 10, 2023 when Morgan Stanley raised their price target to $335. Morgan Stanley previously had an equal-weight for Shockwave Medical Inc.

The last downgrade for Shockwave Medical Inc happened on April 8, 2024 when CL King changed their price target from N/A to N/A for Shockwave Medical Inc.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Shockwave Medical, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Shockwave Medical was filed on April 8, 2024 so you should expect the next rating to be made available sometime around April 8, 2025.

While ratings are subjective and will change, the latest Shockwave Medical (SWAV) rating was a downgraded with a price target of $0.00 to $0.00. The current price Shockwave Medical (SWAV) is trading at is $330.11, which is out of the analyst’s predicted range.